Genomic & Biopharma News

LifeArc, née MRC Technology, sets up high-risk seed fund
LifeArc has set up a seed fund to invest in early preclinical projects that are overlooked because of the high risk of failure at that stage of R&D. The British medical research charity, formerly known as MRC Technology, sees the fund filling a perceived gap in the commercial investment landscape.
Fierce Biotech, 2017-06-14 09:07:39

Alinity: the future of diagnostics?
Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge importance to the running of any healthcare system. Here at Abbott, we believe that providing clinicians with quick access to diagnostics information and insights can help them make quick clinical decisions around the appropriate treatment for a patient,
News Medical Life Sciences, 2017-06-14 09:07:00

MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated Idylla™ platform MRC Technology (‘MRCT’), a medical research charity, and Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today announced a partnership to develop selected molecular diagnostic tests for use on Biocartis’ fully automated Idylla™ platform. MRCT aims to ...
Exosome RNA Research & Industry News, 2017-06-14 09:00:44

Postdoc position available – The mechanistic function and molecular structure of long noncoding RNAs
In the Pyle laboratory at Yale University (www.pylelab.org), we use a combination of cell biology and structural biology techniques to explore the architectural features and functions of large noncoding RNA molecules that control RNA splicing, transcription, pathogenicity, and gene expression. We are looking for highly motivated postdoctoral candidates to conduct pioneering work on the structural ...
lncRNA Research and Industry News, 2017-06-14 09:00:39

Genome-wide profiling of the 3′ ends of polyadenylated RNAs
Alternative polyadenylation (APA) diversifies the 3′ termini of a majority of mRNAs in most eukaryotes, and is consequently inferred to have substantial consequences for the utilization of post-transcriptional regulatory mechanisms. Since conventional RNA-sequencing methods do not accurately define mRNA termini, a number of protocols have been developed that permit sequencing of the 3′ ends of ...
Transcriptome Research & Industry News, 2017-06-14 09:00:25

Korean biotech Orum raises $8M for cell-penetrating antibody tech
Orum Therapeutics has raised a small series A to help push on with its work on a monoclonal antibody designed to treat undruggable cytosolic targets.
Fierce Biotech, 2017-06-14 08:48:35

Menopause linked to severity of lumbar disc degeneration
"Oh, my aching back!" It's not an uncommon complaint heard from both men and women as they age and experience lumbar disc degeneration.
News Medical Life Sciences, 2017-06-14 08:07:59

Survey finds parents to be least knowledgeable about invasive pneumococcal disease
Pfizer Inc., in partnership with Parents magazine, announced today the results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough and invasive pneumococcal disease, and the measures parents can take to help prevent them.
News Medical Life Sciences, 2017-06-14 07:49:23

New survey examines public's opinions on sunscreen at businesses
Skin cancer is by far the most common form of cancer and too much exposure to Ultraviolet (UV) radiation increases the risk of skin cancer.
News Medical Life Sciences, 2017-06-14 07:43:02